CurioWire
EXTRA! EXTRA!

🫀 Secrets of the human vessel

6 Lab Interferences That Mimicked Medical Emergencies

healthPublished 17 Sept 2026 | Updated 12 Oct 2026
6 Lab Interferences That Mimicked Medical Emergencies
B vitamin supplement tablets | Image by Ragesoss, CC BY-SA 3.0
Quick Summary
  • What: The article explains how several known laboratory and immunoassay interferences can produce falsely alarming emergency test results that mimic serious acute illness.
  • Where: Clinical laboratories and emergency-care settings.
  • When: Modern clinical practice.

Emergency lab results are supposed to cut through confusion fast. But some of the most alarming numbers in medicine can be wrong for reasons that have nothing to do with a true crisis.

These six laboratory interferences are known to produce dangerously misleading results in acute settings. The twist is what caused the panic: a supplement, an antibody, a macroenzyme, or even the blood tube itself.

1. Biotin making troponin and thyroid tests lie

High-dose biotin supplements can interfere with certain immunoassays, including tests used for troponin and thyroid function. Depending on the assay design, the result can be falsely low or falsely high.

That is what makes it so dangerous in emergency care. A patient can appear to have a thyroid crisis, or just as seriously, a cardiac marker can be pushed in the wrong direction and distort the picture of possible heart injury.

2. Macrotroponin giving chronically high troponin

Macrotroponin is troponin bound to autoantibodies. On paper, that can look like ongoing heart damage because the troponin stays elevated, sometimes persistently, even when there is no acute myocardial injury.

The surprise is how convincing it can be. Troponin is one of the most trusted emergency markers, so a chronically high result can mimic a serious cardiac problem unless the possibility of macrotroponin is recognized.

3. Heterophile antibodies causing false-positive serologies

Heterophile antibodies, including HAMA-type interference, can create spurious positives on immunoassays. These antibodies can cross-react with test components and generate a result that looks real but is not.

That matters because the confusion is not limited to one disease area. False-positive immunoassay results have complicated diagnoses ranging from serologies such as HIV testing to cardiac markers, turning a lab report into a potential emergency detour.

4. EDTA-induced pseudothrombocytopenia

Sometimes the problem is not the patient but the tube. EDTA, the anticoagulant used in common blood collection tubes, can cause platelets to clump in vitro, which makes automated analyzers report a falsely low platelet count.

The result can look dramatic, as if severe thrombocytopenia has suddenly appeared. In reality, the platelet count may not be dangerously low at all; the apparent emergency is created by clumping after the sample is drawn.

5. Rheumatoid factor skewing immunoassays

Rheumatoid factor is an autoantibody, and in some patients it can interfere with sandwich immunoassays. That can distort measurements of hormones or cardiac markers and produce readings that do not match the clinical picture.

What makes this unsettling is how ordinary the testing process appears. The machine runs, the number prints, and yet the chemistry between the autoantibody and assay can quietly turn a routine result into a misleading one.

6. Hemolysis or lipemia masquerading as metabolic crisis

Not every alarming lab result reflects a real physiologic collapse. Hemolysis and severe lipemia can artifactually alter values such as potassium, lactate, glucose, and electrolytes.

That can make a sample look like a metabolic emergency when the crisis is in the specimen, not the patient. Broken blood cells or a heavily lipemic tube can push numbers far enough to trigger urgent concern.

Together, these interferences show how a lab emergency can be manufactured by assay design, antibodies, protein complexes, or sample artifacts before a diagnosis is ever made.

Did You Know?

Many laboratories investigate suspected macrotroponin by treating the sample with polyethylene glycol (PEG), which can help reveal whether the elevated troponin is due to an antibody-bound complex rather than acute heart injury.